Year archive

NervGen Pharma Corp. — 2025 filings

All 44 regulatory filings released by NervGen Pharma Corp. (NGEN) in 2025, sourced directly from the official regulator.

44 Filings

2025 Period

2025 filings (44)

Filing	Released	Lang
Other.pdf Regulatory Filings	2025-12-18	English
News release - English.pdf Report Publication Announcement	2025-12-17	English
Amendment to (or amended) final short form prospectus – English.pdf Regulatory Filings	2025-12-15	English
News release - English.pdf Regulatory Filings	2025-11-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-11-24	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings 9M 2025	2025-11-24	English
Interim MD&A - English.pdf Management Reports	2025-11-24	English
Interim financial statements/report – English.pdf Regulatory Filings	2025-11-24	English
News release - English.pdf Earnings Release Q3 2025	2025-11-24	English
News release - English.pdf Capital/Financing Update	2025-11-19	English
News release - English.pdf Capital/Financing Update	2025-11-18	English
Material change report - English.pdf Board/Management Information	2025-07-25	English
News release - English.pdf Board/Management Information	2025-07-17	English
News release - English.pdf Capital/Financing Update	2025-07-07	English
Material change report - English.pdf Board/Management Information	2025-07-07	English
News release - English.pdf Board/Management Information	2025-07-01	English
News release - English.pdf Board/Management Information	2025-06-18	English
Material change report - English.pdf Regulatory Filings	2025-06-02	English
News release - English.pdf Regulatory Filings	2025-05-21	English
News release - English.pdf Regulatory Filings	2025-05-16	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2025-05-07	English
News release - English.pdf Regulatory Filings	2025-04-21	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-04-10	English
Other.pdf Regulatory Filings	2025-04-10	English
Other.pdf Proxy Solicitation & Information Statement	2025-04-10	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-04-10	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-04-10	English
News release - English.pdf Capital/Financing Update	2025-04-10	English
Material change report - English.pdf Regulatory Filings	2025-04-05	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-04-03	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-04-03	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-04-03	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-04-03	English
Annual MD&A - English.pdf Regulatory Filings	2025-04-03	English
News release - English.pdf Earnings Release FY 2024	2025-04-03	English
Audited annual financial statements – English.pdf Regulatory Filings	2025-04-03	English
News release - English.pdf Share Issue/Capital Change	2025-03-15	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2025-03-03	English
News release - English.pdf Share Issue/Capital Change	2025-02-18	English
News release - English.pdf Notice of Dividend Amount	2025-02-06	English
News release - English.pdf Regulatory Filings	2025-02-06	English
News release - English.pdf Regulatory Filings	2025-01-29	English
Material change report - English.pdf Regulatory Filings	2025-01-02	English
News release - English.pdf Regulatory Filings	2025-01-02	English